| Trial ID: | L7244 |
| Source ID: | NCT02887677
|
| Associated Drug: |
Dapagliflozin
|
| Title: |
Effects of Dapagliflozin on Central Hemodynamics and Urine Albumin Excretion in Patients With Type 2 Diabetes.
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus
|
| Interventions: |
DRUG: Dapagliflozin|DRUG: Placebo
|
| Outcome Measures: |
Primary: Ambulatory systolic aortic pressure, 12 weeks | Secondary: Ambulatory aortic (central) diastolic blood pressure (DBP), 12 weeks|Ambulatory brachial systolic blood pressure (SBP) and DBP, 12 weeks|Ambulatory augmentation index (AIx), 12 weeks|Ambulatory pulse wave velocity (PWV), 12 weeks|Office brachial SBP and DBP, 12 weeks|Albumin/creatinine ratio (ACR), 12 weeks|Lipid profile (Total-Cholesterol, LDL-Cholesterol, HDL-Cholesterol, triglycerides), 12 weeks|HbA1c, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Hellenic Society for Medical Education
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
85
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2016-10
|
| Completion Date: |
2019-10
|
| Results First Posted: |
|
| Last Update Posted: |
2019-12-03
|
| Locations: |
Ahepa Hospital, Thessaloniki, 54621, Greece|Hippokrateio Hospital, Thessaloniki, 54642, Greece|Papageorgiou Hospital, Thessaloniki, 56429, Greece
|
| URL: |
https://clinicaltrials.gov/show/NCT02887677
|
